Aster to settle RWA perpetuals exclusively in World Liberty Financial’s USD1 stablecoin

March 2026 brought Solana (SOL) what the article describes as its most consequential regulatory win to date, alongside record-breaking real-world asset (RWA) adoption. Together, the developments are reshaping how institutions approach the network. Regulatory milestone: SOL classified as a digital commodity SOL was classified as a digital commodity on March…

SWIFT’s blockchain-based payment rails could be more consequential for XRP than recent price moves, according to a wealth-focused podcast host. The argument is that the most important development for XRP is not driven by legislation or market action, but by “plumbing”: SWIFT’s global payments network moving into operational use with…

JPMorgan Chase CEO Jamie Dimon warned in his annual letter to shareholders that the war in Iran and spiking oil prices could fuel inflation this year, raising the risk that the U.S. and global economies experience stagflation. He also highlighted concerns tied to deteriorating lending standards in private credit markets,…

Metaplanet has added 5,075 Bitcoin to its treasury, bringing its total holdings to 40,177 BTC and strengthening its position among the world’s largest public corporate Bitcoin holders. The Tokyo-listed company said the latest purchase keeps it in third place, behind Strategy and Twenty One Capital. Metaplanet has also set a…

TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) ("TPVG" or the "Company"), a leading financing provider to venture growth stage companies backed by a select group of venture capital firms in technology and other high growth industries, today announced that DBRS, Inc. ("Morningstar DBRS") has confirmed the Company’s investment grade Long-Term…

On March 31, 2026, The Brink’s Company (NYSE: BCO) (“Brink’s”) completed an amendment and extension of its existing credit facility, according to a company release. Credit facility expanded to $3.85 billion The amended and restated credit agreement increases the size of the existing credit facility from $2.225 billion to $3.85…

Cingulate’s 4Q25 update continued to position CTx-1301 toward a potential commercial launch for attention-deficit/hyperactivity disorder (ADHD), with the regulatory focus now centered on manufacturing (CMC) rather than clinical performance. The company stated that its NDA remains under FDA review under the 505(b)(2) pathway. Recent financing, intellectual property progress, and commercial…